Application no. and date | 10173506.6 (espacenet) (Federated) (European Patent Register), 20081104 | Patent/reg. no. and date | DK/EP 2295035, 20160518 | Publication date | 20110316 | Priority no. and date | US 985668 P, 20071106 | EP pub. no. and date |
EP 2295035 20110316 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | SH/AP/153524 | Inventor | RUEGGER, Colleen, 89 Poplar Drive
Morris Plains, NJ 07950, US, ROYCE, Alan Edward, RR 4 BOX 9LE
Saylorsburg, PA 18353, US, Al-Fayoumi, Suliman, 31 Knollwood Drive
Morristown, NJ 07960, US, Hu, Jiahui, 92 Bradley Lane
Bridgewater, NJ 08807, US, Kumaraperumal, Natrajan, 40-B Byrne Court
Wayne, NJ 07470, US, Zannou, Erika Aina, 12 Mary Ellen Drive
Edison, NJ 08820, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/216 (2006.01) , A61K 9/00 (2006.01) , A61K 9/20 (2006.01) , A61K 31/41 (2006.01) | Title | Dobbeltvirkende farmaceutiske sammensætninger baserede på superstrukturer af angiotensinreceptor antagonister/blokkere (arb) og neutral endopeptidase (nep) inhibitorer | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|